文献速递药物不良反应与药物警戒抗栓抗凝管理

肥胖与阿司匹林药理学改变

Obesity and Altered Aspirin Pharmacology.
PubMed 文献 · Clin Pharmacokinet · 2018-01-01

综述探讨肥胖患者阿司匹林药效学反应降低的机制,涉及胰岛素抵抗、炎症、氧化应激和内皮功能障碍驱动的促血栓状态及代谢性内毒素血症。肥胖相关炎症可能增加血小板反应性和周转并降低阿司匹林生物利用度,共同导致阿司匹林反应不佳。

要点

  • 肥胖患者阿司匹林药效学反应降低,与促血栓状态和血小板高反应性相关。
  • 代谢性内毒素血症可能通过增加血小板周转和降低阿司匹林生物利用度导致反应不佳。
  • 理解肥胖相关高血小板反应性机制有助于优化该人群抗栓治疗。

核心结论

  • 肥胖是阿司匹林药效学反应降低的危险因素,机制涉及炎症、血小板周转增加及生物利用度下降。

研究设计与样本

  • 综述,总结肥胖相关促血栓状态与阿司匹林药理学改变的机制文献。

主要发现

  • 肥胖患者存在凝血因子增加、纤溶受损和血小板高反应性,与胰岛素抵抗、炎症、氧化应激及内皮功能障碍相关。
  • 肥胖相关代谢性内毒素血症可能增加血小板反应性和周转并降低阿司匹林生物利用度,导致阿司匹林反应不佳。

临床怎么用

  • 临床应关注肥胖患者阿司匹林药效学反应可能降低,需优化抗栓治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obesity is an independent risk factor for cardiovascular morbidity and mortality due to atherothrombotic events and represents a group of patients who are in need of optimized antithrombotic therapy. Central to the obesity-related risk of atherothrombosis is a pro-thrombotic state characterized by increased levels of coagulation factors, impaired fibrinolysis, and platelet hyper-reactivity, which results from the interaction among the features clustering in obesity: insulin resistance, inflammation, oxidative stress, and endothelial dysfunction. Aspirin is a cornerstone antiplatelet drug that has substantial interpatient variability in pharmacodynamic response and a number of reports have demonstrated that obesity is a risk factor for a reduced aspirin pharmacodynamic response. The inflammatory state associated with obesity, particularly a metabolic endotoxemia, may set in motion a number of mechanisms that increase platelet reactivity and platelet turnover and decrease aspirin bioavailability, all contributing to a poor aspirin response. A greater understanding of the mechanisms underlying obesity-related high on-aspirin platelet reactivity will help in optimization of antithrombotic therapy in this patient population.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Norgard NB. Obesity and Altered Aspirin Pharmacology. Clin Pharmacokinet. 2018. PMID: 29139042. doi:10.1007/s40262-017-0611-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。